| - |
Oral therapy of moderate to severe systemic infections with a |
| |
probability of having mixed aerobic and anaerobic bacterial |
| |
infections. |
| - |
In some cases, cephalosporins and/or aminoglycosides may be |
| |
co-prescribed wherever necessary. |
| - |
These infections include: |
| |
| - |
G.I. infections like appendicitis, cholecystitis. |
| - |
Post-operative infections after abdominal/gynaecological |
| |
operations. |
| - |
Lung infections like bronchiectasis, lung abscess, empyema etc. |
|
| - |
Acute or chronic bone and joint infections |
| - |
Infections in patients with Diabetes Mellitus |
| - |
Infection in immunocompromised patients |
| - |
Oral follow-up of parenteral therapy with Ofloxacin and Ornidazole |
| |
or Tinidazole |
| - |
Acute diarrhoea or dysentery due to bacterial, protozoal or mixed |
| |
infection |
